India Allows Export Of 20 Mln "Novavax" Vaccine To Indonesia: Sources

India has approved the shipment of 20 million doses of the Novavax (NVAX.O) COVID-19 vaccine developed by the Serum Institute of India (SII) to Indonesia, according to reports. Further, the government has also decided to allow 10 million doses of Covishield, also manufactured by SII, to be exported on the global vaccine-sharing program. As per sources, the government has no plans to place an order for Merck & Co.'s COVID-19 pill.